FDA Notices of Judgment Collection, 1908-1966

16557. Adulteration and Misbranding of Capsi-Quin compound tablets and misbranding of glycero-terpin compound. U. S. v. 1 Dozen Bottles of Capsi-Quin Compound Tablets, et al. Default decree of condemnation, forfeiture, and destruction.